Proof of Usefulness Report

Seroba.

Analysis completed on 2/13/2026

+31
Proof of Usefulness Score
You're In Business

The submission describes 'Seroba', a legitimate European life sciences venture capital firm established in 2002. However, the submission quality is critically low, containing significant inaccuracies (claiming a team size of 125 and that 'most people have used' the product, despite it being a niche B2B financial firm). As a non-technology project submitted with erroneous data and zero evidence of technical implementation, it scores very low on the Proof of Usefulness scale compared to verifiable technology products.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+10.0
Audience Reach Impact+4.0
Technical Innovation+0.75
Evidence Of Traction+7.5
Market Timing Relevance+7.0
Functional Completeness+0.25
Subtotal+29.5
Usefulness Multiplierx1.05
Final Score+31

Project Details

Project URL
Description
Investing in life sciences. Investing in life. Seroba is a European life sciences venture capital firm based in Dublin, Paris and Milan, investing its fourth Fund. We focus on value creation through backing cutting-edge biotech and medtech innovation that will transform the treatment of unmet medical needs. Our team has deep industry and operational experience and an extensive global network. We like to work with entrepreneurs who share our passion for success and for investors who share the same goal of improving human health while driving financial returns.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline